For the first time, brand owners can have access to a
ready-to-brand personalized nutrition digital platform
pre-populated with branded food, beverage and supplements targeting
metabolic health
NEW
YORK, Nov. 22, 2022 /PRNewswire/ -- IFF (NYSE:
IFF) today announced its plans for accelerated entry into the
personalized nutrition sector through a strategic partnership with
Salus Optima, a British-based, digitally-enabled personalized
nutrition, health and wellness company. The initial focus for the
partnership will be metabolic health, including obesity,
pre-diabetes, high cholesterol and pre-hypertension, which impacts
over 25 percent1 of the adult population globally.
![](https://mma.prnewswire.com/media/1952216/Salus_Optima_IFF_partnership_with_credit.jpg)
Together, the companies are developing an unmatched capability
to help consumers understand their unique metabolic response to
food, supplements, activity and sleep, accessible via mobile phones
and wearables. By leveraging Salus Optima's core technology with
IFF's portfolio of health-enabling ingredients from its Nourish and
Health & Biosciences business divisions, brand owners can offer
consumers a differentiated and engaging personalized nutrition
experience that addresses the aspects that influence metabolic
health.
"The partnership with Salus Optima places us at the forefront of
the personalized nutrition space," said Nicolas Mirzayantz,
president, Nourish, IFF. "It is a testament to our commitment
to science, creativity and redefining possibilities with our
customers and consumers at the center of it. Our novel approach—an
an end-to-end personalized nutrition offering with best-in-class
ingredient and flavor solutions, together with a scalable digital
capability—is critical to meet the needs of consumers."
Key to the success of the personalized nutrition offering is
blending science-backed, data driven recommendations with
behavioural change techniques, such as digital coaching, with
branded products at the core of the offering.
"We see digital services as an enhancement to – not a
replacement for – the overall personalized nutrition market," said
Sébastien Guery, vice president, IFF Health. Products will always
remain a critical part of health and wellness, but we also
recognize the challenge our customers have in meeting the needs of
their consumers when it comes to personalization. IFF's partnership
with Salus Optima will enable our customers to empower consumers to
make sustainable lifestyle choices to achieve their personal health
and wellness goals with the blend of a physical product and a
digital platform."
Apart from the digital platform, IFF will collaborate with brand
owners to craft specialized wellness products for consumers,
incorporating the company's extensive portfolio of science-backed
and clinically tested ingredients, such as probiotics, prebiotics,
plant proteins and fibers.
Benefits for brand owners include:
- Real-time consumer intel: The technology offers brand
owners a direct marketing tool that captures rich, first-party data
beyond traditional points of sale to help brands serve consumers
better through a deeper understanding of their needs.
- Actionable and easy use: Easy consumer set-up and
integration with mobiles and wearables leading to actionable,
engaging and personalized suggestions to achieve health and
wellness goals.
- Increased speed to market: A turn-key digital health and
wellness platform powered by IFF's market-ready product design
solutions, combined with Salus' modular digital health
technology.
- Increased brand lifetime value: Salus Optima Technology,
providing leading behavior change techniques, has been shown to
increase brand lifetime value as much as double digits by
supporting, motivating and empowering consumers to achieve their
health and wellness goals. This paired with IFF's evidence-based
efficacious ingredients will add further to that brand value.
"By combining IFF's science-led, high-quality,
clinically-studied ingredients and applications expertise with
Salus Optima's world-class digital health and wellness
capabilities, we invest in technology that drives the industry
forward," said Madhusudan Patel,
director, venturing and tech sourcing, Global R&D, IFF.
"At Salus Optima, our mission is to help solve some of the
world's most pressing public health issues by using technology to
democratize best in class-science and amplify human touch through
digital coaching and behavioral change," said Rodrigo Jesus, Salus Optima CEO. "Deploying this
technology on mobile phones and wearables tackles head on the
challenge many consumers face such as accessibility, convenience
and cost. By collaborating with IFF, Salus is confident that we can
empower individuals to make simple and sustainable food, supplement
and lifestyle choices for better human health."
For more information about IFF products and ingredients, visit
www.iff.com.
1
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5866840/
About Salus Optima
Salus Optima is technology global leader in personalised
nutrition and personalised health. Salus Optima's digital products
sit at the intersection of health and wellness, providing holistic
human performance recommendations for healthier life, work and
play. The core technology is built on years of R&D, tackling
the real problems people face in their everyday lives. By making
the best scientific methodologies accessible to the population,
Salus Optima empowers people by giving them greater control over
their own health and wellbeing.
Salus Optima's products help health-conscious, well and at-risk
individuals looking to take proactive, preventative measures to
remain healthy.
About IFF's Nourish division
At IFF, we're united by a
common goal: to apply science and creativity for a better world.
Across our business divisions, we're on a mission to Do More Good
for our people, customers, and communities.
To us, "nourish" means "to feed with purpose" — and we're here
to redefine the industry by nourishing people, products, and our
planet. Every day, our teams are boldly reimagining and pioneering
the next generation of food and beverage experiences. We're
leveraging our industry-leading product portfolio, unmatched
innovation capabilities, and customer-centric approach to become
the partner for essential solutions. Let's nourish the future,
together.
About IFF's Health & Biosciences division
Inspired by nature and distinguished by its world-class
bioscience and microbiome capabilities, IFF's Health &
Biosciences division is a leading innovation partner for customers
across a broad range of consumer product, industrial and
agricultural sectors. IFF's Health & Biosciences division works
closely with our customers to enhance products – and their
processes – to deliver safer, healthier and more sustainable
solutions.
Welcome to IFF
At IFF (NYSE: IFF), an industry leader in food, beverage,
health, biosciences and sensorial experiences, science and
creativity meet to create essential solutions for a better world –
from global icons to unexpected innovations and experiences. With
the beauty of art and the precision of science, we are an
international collective of thinkers who partners with customers to
bring scents, tastes, experiences, ingredients and solutions for
products the world craves. Together, we will do more good for
people and planet. Learn more at
iff.com, Twitter , Facebook, Instagram,
and LinkedIn.
©2022 International Flavors & Fragrances Inc. (IFF). IFF,
the IFF Logo, and all trademarks and service marks denoted with ™,
SM or ® are owned by IFF or affiliates of IFF
unless otherwise noted. All Rights Reserved.
Contact:
Victoria Oei
Global External Communication Lead
victoria.oei@iff.com
+65 9845 7580
SOURCE IFF